<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Eli Lilly Reports Positive Topline Results in Phase 3 Leukemia Study â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Eli Lilly Reports Positive Topline Results in Phase 3 Leukemia Study</h2>
    <div class="badge">2025-09-08T11:23:57+00:00</div>
    <ul>
      <li>Eli Lilly Reports Positive Topline Results in Phase 3 Leukemia Study Eli Lilly (LLY) said Monday that topline results from its phase 3 trial evaluating Jaypirca showed c Upgrade to read this MT Newswires article and get</li>
<li>A Silver or Gold subscription plan is required to access premium news articles.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Eli%20Lilly%20Reports%20Positive%20Topline%20Results%20in%20Phase%203%20Leukemia%20Study%0A%E2%80%A2%20Eli%20Lilly%20Reports%20Positive%20Topline%20Results%20in%20Phase%203%20Leukemia%20Study%20Eli%20Lilly%20%28LLY%29%20said%20Monday%20that%20topline%20results%20from%20its%20phase%203%20trial%20evaluating%20Jaypirca%20showed%20c%20Upgrade%20to%20read%20this%20MT%20Newswires%20article%20and%20get%0A%E2%80%A2%20A%20Silver%20or%20Gold%20subscription%20plan%20is%20required%20to%20access%20premium%20news%20articles.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Feli-lilly-reports-positive-topline-results-in-phase-3-leukemia-study%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/eli-lilly-reports-positive-topline-112357424.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>